Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for...

Nektar Therapeutics (Nasdaq: NKTR) today presented preclinical data on its immuno-oncology pipeline candidates, bempegaldesleukin (NKTR-214 or bempeg), a CD122-preferential IL-2 pathway agonist,...

Digital Cinema Implementation Partners, LLC (DCIP) announced today that Fathom Events, the recognized leader in the event cinema industry, has completed the rollout of DCIP's Cinergy Event...

QAD Precision, an industry-leading provider of global trade management and transportation execution solutions, will speak and host a workshop at this year's Internet Retailing Expo (IRX) and...

Mad*Pow's Center for Health Experience Design and Health 2.0 Advocates announce a Design Challenge, funded by the Robert Wood Johnson Foundation, for the health and design communities to envision...